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Summal"y 
To determine the functional role of the two isoforms of Fc3,RIII (CD16) (IliA, IIIB), the signal 
transduction capabilities  of wild-type and mutant forms of these receptors were analyzed  in 
transfected lymphoid, myeloid, and fibroblastic cell lines. Functional reconstitution of receptor 
signalling was observed in hematopoietic T and mast cells, and was absent in nonhematopoietic 
(CHO)  cells. 
Fc~RIIIA, a hetero-o[igomeric receptor composed of a ligand-binding subunit c~ and dimeric 
3/chains, generated both proximal and distal responses in Jurkat and P815 cells, typical of what 
is seen in natural killer cells and macrophages upon receptor activation. In contrast, Fc3/RIIIB, 
which is normally attached to the cell surface via a glycosyl-phosphatidylinositol anchor, was 
incapable of transducing signals. After crosslinking, Fc3,KIIIA  signalling was dependent only 
upon the 3, chain. Fc3/RIIIA chimeras in which the ol subunit transmembrane and cytoplasmic 
domains were substituted with the corresponding 3/chain sequences functioned as well as wild- 
type hetero-oligomeric receptors.  These data indicate that the ability of the FcyRIIIA complex 
to activate the appropriate pathways  for cell activation is cell-type restricted and independent 
of the transmembrane and cytoplasmic domains of the c~ subunit. The presence of the 3/chain 
is responsible for the assembly of, as well as the signal transduction by, the functional cell surface 
complex. 
B 
inding of antibodies to effector cells through receptors 
recognizing their constant regions (FcR) is central to 
the pathway that leads to clearance of antigens by pinocy- 
tosis of immune complexes, phagocytosis of antibody-coated 
particles,  or  antibody-dependent  cellular  cytotoxicity 
(ADCC) 1 (1). FcRs act as sigual-transducing molecules and 
thus provide an important link in the communication be- 
tween the innate and the adaptive immune systems. Receptors 
for the Fc domain of IgG are present on most hematopoietic 
cells,  including B-,  T-,  and  NK  cells, macrophages and 
neutrophils, and most cell types coexpress different forms of 
FcP.s (2). 
Three classes of human FcR for IgG (Fc3/R) have been 
defined based upon their different protein and genomic struc- 
tures: the high-af~nity Fc3/RI (CD64), and the low-af~nity 
Fc3/Rs FcyRII (CD32) and Fc3/RIII (CD16) (3). Evidence 
suggests that Fc'yRs couple ligand binding to intracellular 
signalling events, but the contribution of each particular type 
of Fc3/R to the overall cell activation process is still unknown. 
1 Abbreviations used in  this paper." ADCC,  antibody-dependent  cellular 
cytotoxicity;  GPI, glycosyl-phosphatidylinositol;  PI-PLC, phosphatidy- 
linositol-specific phospholipase C; PNH, acquired paroxysmal nocturnal 
hemoglobinuria. 
Although many early biochemical events such as stimulation 
of phospholipase C,  mobilization of intracellular calcium 
([Ca2+]1), and activation of protein kinase C are thought to 
occur after occupancy and cross[inking of these receptors (1-3), 
the molecules that are responsible for these phenomena have 
not been unambiguously identified. 
To clarify the functional role of FcRs, we have examined 
the properties of the low-af~nity Fc'yRIII, which exists in 
two isoforms.  The appearance of these two isoforms is the 
consequence of a small number of single nucleotide substitu- 
tions in the two genes coding for Fc3/RIIIA and Fc3/RIIIB, 
leading to either a conventional transmembrane molecule with 
a distinct cytoplasmic domain, or a glycosyl-phosphatidyl- 
inositol (GPI)  linked protein, respectively  (4-6).  Both iso- 
forms have nearly identical extracellular domains, and there- 
fore demonstrate identical ligand-binding specificities. The 
monomeric GPI-linked Fc3,RIIIB is uniquely expressed on 
neutrophils (7,  8),  while the other isoform, Fc3/RIIIA, is 
expressed on NK cells and on macrophages, and exists as a 
hetero-oligomeric receptor complex consisting of a ligand- 
binding ol chain associated with disulfide-[inked 3, or ~'chains 
(9-13).  The associated 3, or ~" chains are required for cell sur- 
face expression of FcyRIII~. c~, and are presumed to be in. 
volved in signal transduction (9-12).  The 3, and ~" subunits 
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timeric high-affinity  FcR for IgE (Fcd~I), and the TCR/CD3 
complex, respectively  (14, 15). 
To explore the capability of the different isoforms of FcTRIII 
to generate intracellular signalling events, we have introduced 
the respective  genes for FcTRIIIA and FcTRIIIB into the 
FcR.-deficient human leukemic T cell lineJurkat, the murine 
mast cell line P815, and fibroblastic CHO cells, and subse- 
quently analyzed the capabilities of these receptors to mediate 
early and late cell activation events elicited by mAbs specific 
for FcTRIII. 
Our data indicate that FcyRIIIB is not able to mediate 
any of the responses examined. However, the FcTRIIIA com- 
plex, upon engagement with mAbs and subsequent cross- 
linking  with  secondary  antibodies,  resulted  in  responses 
indistinguishable from the ones initiated by TCR/CD3 acti- 
vation of  Jurkat cells, or FcTRIIIA (CD16) activation of NK 
cells. A mutant Fc3,RIIIA complex lacking the cytoplasmic 
domain of the ot chain demonstrated the same activation profile 
as  the  wild-type receptor  complex.  Similarly,  a  chimeric 
receptor, composed of the extracellular domain of FcyRIIIAot 
coupled to the transmembrane and cytoplasmic domains of 
y, was sufficient to elicit intracellular responses.  These data 
suggest  that  the expression  of the associated  y  chains of 
FcTRIIIA are necessary to prevent the complex from (ER) 
endoplasmic reticulum degradation (16) and cell surface ex- 
pression of the receptor complex (9-11), and are also required 
in transducing the signal initiated by occupancy of the ligand- 
binding c~ chain of the complex. 
Materials  and Methods 
Reagents.  Fura-2  acetoxymethyl  ester (fura-2/AM) was obtained 
from Molecular Probes, Inc. (Eugene, OR). Phorbol 12-myristate 
13-acetate (PMA), ionomycin, and A23187 were from Calbiochem 
Corp.  (La Jolla, CA).  12sI(100 mCi/ml), myo-[3H]-inositol (92 
Ci/mmol),  [32p]orthophosphate (10 mCi/ml), and [3H]thymidine 
(20 Ci/mmol) were obtained from Amersham Corp. (Arlington 
Heights, IL). Geneticin (G418) was obtained from Gibco Labora- 
tories (Grand Island, NY). 1,3,4,6-tetrachloro-3tx,6~-diphenygly- 
couril (Iodogen) was purchased from Pierce Chemical Co. (Rock- 
ford, IL). Phosphatidylinositol-specific  phospholipase C (PI-PLC, 
isolated from Bacillus cereus) was from Boehringer Mannheim Corp. 
(Indianapolis, IN). All other reagents  were from Fluka Chem. Corp. 
(Ronkonkoma, NY). 
mAbs.  The following  antibodies were used: mouse anti-human 
CD3e: OKT3 (IgG2a, Ortho Diagnostic Systems, Inc., Raritan, 
NJ); mouse anti-human CD16:3G8 (IgG1, prepared in vitro from 
3G8 hybridoma (17) grown in a hoUow fiber cartridge, Mini Flo- 
Path; Amicon, Beverly,  MA) purified  with goat anti-mouse (GolM) 
IgG-coupled agarose (Sigma  Chemical Co., St. Louis, MO); mouse 
anti-human CD64:32.2 (IgG1, Medarex, Inc., West Lebanon,  NH); 
mouse anti-human  IL-2 receptor ~ chain (IL-2R~; CD25, IgG1, 
biotin conjugate;  Boehringer  Mannheim);  mouse  anti-phosphotyro- 
sine: 4G10 (IgG2bk; Upstate Biotechnology  Inc., Lake  Placid, NY); 
GotM IgG P(ab')z flee of intact IgG by silver stain analysis  of SDS- 
PAGE analytical gels (Tago Inc., Burlingame, CA). 
Cell Lines.  Jurkat T cells were cultured in medium containing 
RPMI 1640 supplemented with 10% heat-inactivated  FCS, gluta- 
mine (2 mM), nonessential amino acids (0.1 raM), penicillin (100 
U/ml), streptomycin (100/xg/ml)  at 37~  5% CO2. P815 and 
CHO cell  lines were cultured in the same medium, but RPMI 1640 
was replaced  by MEM-c~ and DME, respectively.  All cell lines were 
checked regularly for the presence of mycoplasma  and eventually 
cured with mycoplasma removal agent (ICN Biomedicals, Inc., 
Costa Mesa, CA). 
FcTRIII Expression Vectors.  cDNA encoding the glycosyl  phos- 
phatidylinositol (GPI)-linked form of human FcTRIII(FcTRIIIB  ) 
(5) was cloned into the expression vector pfNeo (18). cDNAs en- 
coding human FcTRIIIAc~ and murine FceRI7 were cloned to- 
gether with the neomycin  resistance  gene into the expression  vector 
pcEXV-3 (pcEXV-3N/Fc3'RIIIAc~+  3') (19). A cytoplasmic dele- 
tion clone of Fc3'RIII was described previously (Fc3'RIIIB with 
Set203 changed to Phe) (11). This mutated cDNA was cloned to- 
gether with the cDNA encoding the 3' chain and the neomycin 
resistance gene into pcEXV-3 (pcEXV-3N/Fc3"RIIIAcc(A)+  3'). The 
chimeric FcTRIIIAet/7, which contains the extracellular domain 
of Fc3"RIIIAc~ attached directly to the transmembrane and cyto- 
plasmic portions of FceRI"/, was constructed using PCR methods, 
and cloned  together with the neomycin  resistance  gene into pcEXV-3 
(pcEXV-3N/Fc3'RIIIot/3'). The resulting plasmids were verified 
by dideoxynucleotide DNA sequence analysis. 
DNA  Transfection.  Jurkat cells were transfected by electropo- 
ration, as previously described (20). 48 h after transfection, cul- 
tures were adjusted to an active concentration of 0.5 mg/ml G418 
sulfate (Geneticin; Gibco Laboratories). After 1 wk, the concen- 
tration of  G418 was increased  to 1 mg/ml. Cultures were fed weekly. 
Growing clones  were detected 3-4 wk after transfection,  expanded, 
and screened for Fc3"RIII  expression by flow cytometry. Fc3'RIII  + 
cells were isolated  using the anti-FcTRIII  mAb 3G8, and Dynabeads 
coated with Gc~M IgG (Dynal Inc., Great Neck, NY). All trans- 
fected  Jurkat clones were kept in selective  medium, and have been 
phenotypically stable for Fc3'RIII expression for more than 6 mo 
of continuous culture. P815 cells and CHO cells were transfected 
using the calcium-phosphate method, selected in the presence of 
G418, and cloned as described above. 
Flow  Cytometric Analysis.  Cells (106/50 #l)  were incubated 
with 50/xl of antibody (1/~g/ml) for 30 rain at 4~C. Cells were 
washed twice with PBS containing 0.25% BSA (PBS/BSA), and 
were subsequently  incubated with 50/xl of FITC-conjugated Gc~M 
IgG F(ab')z (1/~g/ml; Tago Inc.). Cells were resuspended in 300 
/xl PBS/BSA and analyzed using a FACScan  |  (Becton Dickinson 
& Co., San Jose, CA). 
Cell-Surface Labeling and Immunoprecipitation.  107  cells were 
surface-labeled with  nSl  by  using  1,3,4,6-tetrachloro-3ot,6c~- 
diphenylglycouril.  Labeled  membrane proteins were extracted with 
lysis buffer containing 1% digitonin and 0.12% Triton X-100. For 
immunoprecipitation, cell lysates  were sequentially  incubated (2 h, 
4~  for each incubation) with indicated antibodies and with pro- 
tein A sepharose CL4B or protein A sepbarose CL4B coated with 
ILeuM IgG antibody (Pharmacia LKB Biotechnology, Inc., Pis- 
cataway, NJ), and washed with digitonin buffer four times. Im- 
mune complexe~ were eluted into sample buffer and separated on 
10%  tricine/SDS-PAGE. Autoradiographic exposures were done 
at  -70~  for 3 d. 
Measurement of[Ca2+],.  Measurements  of intracellular free cal- 
cium levels were performed with fura-2/AM. Cells (5  ￿  1@) were 
washed once and loaded with 3/zM of fura-2/AM in 500 #1 of 
a 50-raM Hepes buffer (pH 7.2) supplemented  with 150 mM NaC1, 
1 mM CaClz, 0.5 mM MgC12, 5 mM KC1, 1 mM Na2HPO4, and 
5 mM glucose. After 15 rain of incubation at 37~  the cell sus- 
pension was diluted to 106 cells/ml with the same buffer, and in- 
cubated for an additional 30 rain at 37~  Cells were washed twice 
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cells were pre-equilibrated at 37~  for 10 min. Fluorescence  of the 
stirred cellular suspension was continuously monitored with an A1- 
phascan fluorimeter (Photon Technology International Inc., New 
Brunswick, NJ). [Ca  2§ ], was measured and computed as described 
previously (21). 
Phosphoinositide Hydrolysis.  Jurkat cells or P815 cells were la- 
beled with myo-[3H]-inositol  (10 #Ci/ml, 106 cells/ml) for 6 h in 
inositol-free RPMI 1640 supplemented with 10% dialyzed FCS. 
The cells (5  x  10e/ml) were pre-equilibrated at 37~  and sequen- 
tially stimulated with 3G8 (1 #g/ml) and GotM IgG F(ab')2 (10 
#g/ml) in the presence of 10 mM LiCl. The soluble inositol phos- 
phates were extracted with TCA (200 #1) and applied to 1 ml of 
AG 1-X8 (formate form) 1 ml ion exchange columns (Bio-Rad 
Laboratories, Richmond, CA) pre-equilibrated with 0.1 M formic 
acid. After loading of the samples, columns were washed with 10 
ml H20 and 10 ml 60 mM ammonium formate/5 mM disodium- 
tetraborate, and elution was performed with increasing concentra- 
tions of ammonium formate (0.1-0.7 M) (22). The eluted radioac- 
tivity was quantified by liquid scintillation counting in Aquasol 
(NEN  DuPont,  Boston, MA). 
Tyrosine Phosphorylation.  For tyrosine phosphorylation analysis, 
2  x  106 cells were incubated for 3 h at 37~  in 800/*1 phosphate- 
free DME supplemented with 0.5% dialyzed BSA and glutamine. 
The cells were labeled with [32P]orthophosphate (1 mCi/ml) for 
4 h at 37~  and stimulated with mAbs for 2.5 rain, and with 
or without crosslinking by Gc,  M IgG F(ab')2 for an additional 2.5 
min. Cells were pelleted and resuspended in 300 #1 lysis  buffer (50 
mM Hepes (pH 7.45), 150 mM NaC1, 1% digitonin, 5 mM EGTA, 
50/*g/ml leupeptin, 10/,g/ml aprotinin, 2/xg/ml pepstatin, I mM 
PMSF, 200 #M sodium orthovanadate, 20 mM NaF, and 20 mM 
sodium pyrophosphate), incubated at 4~  for 1 h, and clarified 
by centrifugation at 14,000 rpm for 15 rain at 4~  Immunoprecipi- 
tations were carried out from supernatants by addition of 1 #g 
antiphosphotyrosine  mAb 4G10 for 16 h at 4~  Protein A sepharose 
CL4B (Pharmacia LKB Biotechnology, Inc.) was added for 1 h, 
then the immune complexes were washed three times with lysis 
buffer and prepared for SDS-PAGE (10%). Autoradiograms were 
exposed at 20~  for 16 h. Each lane represents "2  x  10  ~ cells. 
IL2 Production  and II_,2R Expression.  Jurkat cells were incubated 
with the indicated mAbs for 30 min at 4~  After removal of un- 
bound  antibody,  the  cell concentration  was  adjusted  to  10  s 
cells/ml, and 200 #1 aliquots were transferred to 96-well microtiter 
plates that were precoated  with Gc~M IgG and blocked with RPMI 
plus 10% FCS. PMA and A23187 were added at final concentra- 
tions of 10 ng/ml and 1/~M, respectively. After 36 h of culture, 
IL-2 activity was assessed by measuring [3H]thymidine uptake of 
the IL-2-dependent cell line CTLL in a 1:4 dilution of the test su- 
pernatants. Means of triplicate determinations are given. SD were 
<10% of the means. Neither PMA, A23187, nor any of the mAbs 
used in this study had effects on this assay by themselves. 
IL-2Rcr expression was determined by flow cytometry of stimu- 
lated cells using biotin-coupled IL-2Rc~ mAb and FITC-coupled 
streptavidin  (Boehringer Mannheim,  Inc.) using  a  FACScan  | 
(Becton Dickinson & Co.). 
Results 
Expression of Ehfferent lsoforms of ~cTRIII on TransfectedJurkat 
Cell Lines.  The stable  expression  plasmids for Fc3'RIIIB, 
Fc3'glIIAcr  "~ and Fc3"RIIIAc~(A)+ 3' were linearized by 
restriction enzyme digestion and introduced into recipient 
Jurkat T cells using electroporation. Flow cytometry of the 
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established cell lines showed that the different forms of Fc3'RIII 
were equally expressed  on the transfected Jurkat cells (Fig. 
1 A). Cell surface expression of FeyRIIIAc~ and Fc3,RIIIAoe(A) 
were obtained only by cotransfection with the y  chain. As 
expected, Fc3"RIIIB was susceptible to digestion with PI-PLC, 
while FcyRIIIAot+ 3' and Fc3"RIIIAc~(A) + 3' were resistant 
(Fig.  1 A). 
To confirm the flow cytometric data and to determine the 
subunit composition of the receptor complexes,  cells were 
surface labeled with radioactive iodine and subsequently lysed 
under mild detergent conditions to preserve receptor com- 
plexes. The FeyRIII isoforms were immunoprecipitated from 
the lysates using a variety of antibodies (Fig.  1 B). 3G8, a 
mAb directed against the extracellular domain of FcTRIII, 
immunoprecipitated a broad band of protein from cells ex- 
pressing Fc3'RIIIB characteristic of this glycoprotein (Fig. 
1 B, 3G8). Polyclonal antiserum raised against the cytoplasmic 
domain of Fc3'RIIIAot did not react with extracts from the 
same cells (data not shown). 
Immunoprecipitation from extracts of  Jurkat cells expressing 
FcyRIIIAol+  3' with the anticytoplasmic  antibody of FcTRIIIAo~ 
resulted in two major bands: the c~ and the 3' chains of the 
receptor complex (Fig. 1 B, oe). Similarly, when extracts from 
these cells were reacted with an antiserum against the 3' chain, 
the same bands were observed,  confirming the association 
of the ol and 3' chains in the receptor complex (Fig.  1 B, 
3')- The faint bands appearing between the ot and y  chains 
at about 30 kD are likely to represent  components of the 
endogenous TCR/CD3 complex that have been shown to 
associate with FceRI3' (23).  Extracts from Jurkat cells ex- 
pressing the mutant Fc3'RIIIAol(A) + 3' complex reacted only 
with 3G8 or the 3' antiserum (data not shown).  None of 
the immunoprecipitating antibodies reacted with molecules 
from extracts of nontransfected parental cells (data not shown). 
Thus, Fc3"RIIIB appears not to be associated with any other 
molecule, while Fc3'RIIIAoe is preferentially associated with 
the cotransfected FcERI3', rather than with the endogenous 
TCR/CD3~'. As we have found in COS cells (11), complex 
formation of cr and 3' in Jurkat cells is independent of the 
cytoplasmic domain of Fc3'RIIIIAcr. 
The molecular appearance of the FcyRIII isoforms in Jurkat 
cells  reflects  the  situation in  vivo,  where  on  neutrophils 
Fc3,RIIIB is expressed as a GPI-linked monomer (4-8), while 
on NK cells or macrophages Fc3'RIIIA appears as a receptor 
complex consisting of one membrane spanning c~ chain as- 
sociated  with either a 3'2 or ~'2 homodimer, or a 3"/~ het- 
erodimer (9,  12,  13). 
Crosslinking  of Fc3"RIlIA  Leads to an Increase in [Ca2+],. 
The FcyRIII-expressingJurkat cells allowed us to determine 
the signalling capacity of these molecules in the absence of 
other FcRs. We therefore examined the ability of 3G8 to elicit 
an increase in [Ca  2+ ], in Jurkat cells transfected with Fc3"R- 
IIIAo~  + 3~ Fc3'RIIIAoL(A)+ ~  or Fc3"RIIIB. Fig. 2 depicts 
typical fluorometry tracings obtained with the different Jurkat 
clones upon stimulation of Fc3"RIII or TCR/CD3, and sub- 
sequent crosslinking of the antibody-coated cell surface mol- 
ecules with GotM IgG F(ab')2. Stimulation of the wild-type 
Fc3'RIIIAoe+ 3' complex and the cytoplasmic deletion clone Figure 1.  (A) Cell  surface expression and PI-PLC  sensitivity  of different  isoforms  of Fc')'Rlll  in transfected  T cells. NontransfectedJurkat  cells were 
used as the control. Indicated  cell lines were incubated  with 3G8 followed  by labeling with fluorescein-conjugated  Gc~M F(ab')2 (solid lines). Non- 
specific staining  was assessed  by using an isotype-matched  negative  control mAb 32.2 (dotted  lines). To assess PI-PI.C sensitivity,  cells were incubated 
in PBS/0.5% BSA in the presence of PI-PLC (2.5 U/ml) at 37~  for 90 min before flow  cytometric  analysis  (dashed  lines). (B) Immunoprecipitation 
of surface-iodinated  Jurkat cells expressing  Fc~RIII.  Surface  radio-iodinated  cells were lysed  in 1% digitonin  lysis  buffer  and immunoprecipitated  with 
anti-Fc'yRllI  mAb 3G8, antiserum  raised against the cytoplasmic  portion of Fc3'RIIIAc~  (tx) or anti-FceRIy  antiserum  (31). Immunoprecipitates  were 
analyzed  under  reducing  conditions  by gel electrophoresis,  followed  by autoradiography.  The weaker signals  obtained  using  3G8 are due to lesser  immu- 
noprecipitation  potency  of this mAb compared with the polyclonal  ~ and 3' antibodies.  Overexposure  of Fc'yRIIIB  did not show  any associated  bands. 
The respective  clones and antibodies  used are indicated. Each  lane represents ~107 cells. Positions  of the molecular  weight standards  are indicated  (kD). 
Fc3"RIIIAot(AI)+ y  with 3G8 and subsequent cross/inking 
resulted in transient rises in [Ca2+]i. The concentration of 
3G8 as shown in Fig. 2 was chosen to give an optimal in- 
crease after addition of the crosslinking GotM IgG F(ab')2. 
Higher concentrations of 3G8 resulted in a brisker increase 
in [Ca2+]i, but with no further response  after crosslinking 
with GaM  IgG F(ab')2 (data not shown).  Stimulation of 
Fc3'RIIIB with 3G8 and subsequent crosslinking with GotM 
IgG  F(ab')2 resulted  in  no  detectable increase  in  [Ca2+]i. 
OKT3 was used as a positive control in all cell lines examined. 
Stimulation  of FcyRIIIA  Results  in Activation of PIP2 Hy- 
drolysis and Tyrosine Kinase Pathways.  Since the increases in 
[Ca2+]i that occur with TCR/CD3 stimulation are attrib- 
uted to increases in inositol phosphates, we tested the ability 
of Fc3'RIII to induce PIPs  hydrolysis by assessing changes 
in total soluble inositol phosphates after stimulation with 3G8 
(Fig. 3 A). Stimulation of the Fc3'RIIIA complex with 3G8 
resulted in the generation of inositol phosphates in both the 
wild-type Fc',/RIIIAc~+ 3, and the cytoplasmic deletion mu- 
tant FcyRIIIAot(A)  + 3~ In contrast, no inositol phosphates 
were generated after stimulation of Fc3'RIIIB in transfected 
cells. Although the initial increase of PIPs hydrolysis in cells 
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expressing FcyRIIIAot+ 3, and Fc3'RIIIAa(A) + 3' was only 
minor, subsequent crosslinking of the 3G8 coated cells led 
to a considerable increase in the generation of inositol phos- 
phates. No such increase was observed in nontransfected  Jurkat 
cells (Fig. 3 A). These results are consistent with the calcium 
fluorometry data and confirm the ability of Fcyl~IIIA to ac- 
tivate PIPs  hydrolysis. 
Stimulation of TCR/CD3  in T  cells, Fc3'RIIIA in NK 
cells and macrophages, and FceI~I in basophils and mast cells 
activate  tyrosine phosphorylation, in addition to PIP2 hy- 
drolysis (24-27). We therefore sought to determine if activa- 
tion via Fc3'RIII would result in tyrosine kinase activation 
in our assay system as well. Immunoprecipitation with an- 
tiphosphotyrosine antibodies from 32p-labeled cell extracts 
revealed that a small number of tyrosine phosphoproteins  were 
present in all unstimulated cells. (Fig.  3 B, Control lane). 
Stimulation of cells with 3G8 or the crosslinking GotM IgG 
F(ab')2  alone  had  no  effect  in  the  different  Fc3,RIII- 
expressing Jurkat cells. Subsequent crosslinking of  3G8 coated 
cells with GaM IgG F(ab')2 resulted in the appearance  of 
a  pattern  of tyrosine phosphoproteins  in  cells  expressing 
Fc3'RIIIAa+ 3' and Fc"/RIIIAot(A) + y that was indistinguish- 
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Figure 2.  Calcium mobilization by Fc3,RIII in  transfected  Jurkat 
cells. Nontransfected  Jurkat cells, cells transfected with  FcyRIIIB, 
FcyRIIIAoe+  3~ or Fc'yR.IIIAoe(A)  + 3, loaded  with fura-2/AM  were  stimu- 
lated with anti-Fc'yRIII mAb (3G8; 0.1 #g/ml), or anti-CD3e mAb 
(OKT3; 1/~g/ml), and subsequently  crosslinked  with GotM F(ab')z (10 
#g/ml). Ionomycin  (1 #M) was used as a receptor-independent  control. 
Cells were analyzed  for changes in [Ca2+]i by fluorometry  as described 
in Materials and Methods. (Arrows)  Stimuli added. 
able from that seen after stimulation with OKT3 and cross- 
linking. Thus FcyRIIIAot+ 3' and F~RIIIAol(A) + 3` are both 
able to activate tyrosine phosphorylation in a manner analo- 
gous to that of the TCR/CD3 complex. No stimulation was 
detected in cells expressing Fc3`RIIIB  and in nontransfected 
control cells. 
Stimulation of  FcTRIII Results in Late Events ofT Cell Acti- 
vation.  T  cell activation results from the transmission of 
receptor-mediated signals from the cell surface to the nucleus 
where they act to induce expression of specific genes (28). 
The expression of the IIr  gene is tightly regulated, requiring 
the integration of a number of signals for its transcription, 
and making it a valuable distal marker for assessing signalling 
through cell surface receptors. 
A significant increase in II:2 production was found in cells 
that were sequentially stimulated with OKT3 and crosslinked 
with immobilized GoeM IgG (Fig.  4 A). Stimulation with 
3G8 resulted in a comparable increase in 11.-2 production, but 
only in the cells expressing either FcyRIIIAoe+ 3' (Fig. 4 A) 
or FcyRIIIAc~(A)+ y  (data not shown). 
Another gene that is used as an activation marker in T 
cells encodes the Ib2 receptor o~ chain (Ib2Ro~, CD25) (28). 
Although the level of IL-2R expression after stimulation with 
3G8 is lower than with OKT3, the pattern of induction is 
similar to the one observed for IL-2 production (Fig.  4 B). 
These data demonstrate that in addition to early signal trans- 
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duction events, late activation events occur upon stimulation 
of Fc3`RIIIA, but not Fc3`RIIIB, thus demonstrating its ability 
to couple to the relevant signal transduction pathways in a 
physiologic manner. The cytoplasmic domain of FeyRIIIAc~ 
subunit is not necessary for either the early or the late activa- 
tion events examined here. 
Signal Transduction by Fc'yRIII in I)815 Cells.  Jurkat cells 
are a useful model to compare the stimulatory potency of 
the different isoforms of Fc~RIII, but since Fc3`RIIIA is nor- 
mally expressed in cells of the myeloid lineage (NK cells, mac- 
rophages, and mast cells),  we have also analyzed its signal- 
transducing capabilities  in the murine mastocytoma cell line 
P815.  P815  cells  express  endogenous murine Fc3`RII  and 
Fc3`RIII, but are deficient in the expression of FcegI (29, 
30). To investigate in detail the functional properties of the 
different subunits of the receptor complex, P815 cells were 
transfected with FcyRIIIAa+ 3, and with a chimeric mole- 
cule composed of the ligand-binding (extraceUular) domains 
of FcyRIIIAoe coupled to the transmembrane and cytoplasmic 
domain of FceRI7 (Fc3`RIIIAoe/3,). 
G418 resistant clones were selected and analyzed for the 
expression of the transfected cell-surface receptors by FACS  | 
(Fig.  5). Receptor activation was performed using 3G8 and 
GaM F(ab')2, free of contaminating intact IgG. Functional 
analysis of the resulting 1)815 clones expressing FcVRIIIAa+ 3, 
and Fevl~IIIAol/3`, respectively, reveal receptor-triggered tran- 
sient increases  in [Ca2+]i,  and induction of PIP2 hydrolysis 
(Fig. 6 B). These experiments validate the Jurkat cell model 
and confirm the ability of Fc3`RIIIAo~+ 3' to elicit proximal 
signal transduction events in a myeloid background. As was 
found in Jurkat cells, the cytoplasmic domain of the c~ chain 
is not necessary for signal transduction, requiring only the 
presence of the transmembrane and cytoplasmic domains of 
the 3~ chain to induce both transient changes in [Ca2+]i and 
induction of PIP2 hydrolysis. The weaker response elicited 
by the chimeric Fc3`RIIIAcff3` upon activation with 3G8 can 
be explained by the decreased level of surface expression of 
this construct compared with FcyRIIIAoe+ 3~ (Fig.  5). 
Finally, to investigate if the signal transduction events trig- 
gered by the FcvRIIIA complex require cell-type specific mol- 
ecules in addition to the o~ and 3' chains, we studied these 
hetero-oligomeric complexes in CHO cells. CHO cells ex- 
pressing FcyRIIIAoe together with the murine FceRI3~ chain 
are incapable of triggering [Ca2+]i or PIP2 hydrolysis after 
stimulation with antireceptor antibodies, or in combination 
with crosslinking GoLR IgG F(ab')2 (data not shown). These 
results indicate that activation through Fc3`RIIIA complex 
is restricted to cell types of lymphoid and myeloid origin. 
Discussion 
Progress in understanding the role of specific Fc3`Rs and 
their associated subunits in signal transduction has been hin- 
dered by the fact that most cell types express multiple types 
of FcTRs. Attempts to trigger individual Fc3`Rs on a single 
cell type have relied upon the use of specific mAbs that recog- 
nize discrete classes of receptors. However, each Fc3,R class 
represents multiple isoforms that differ in their cytoplasmic Figure 3.  (A) Stimulation  of PIP2 hydrolysis  in Jurkat 
cells expressing Fc~/RIII. Cells loaded with myo-[3H]- 
inositol were stimulated  at 37~  with either OKT3 (1 
/~g/ml) alone  (open bars), OKT3 and crosslinking  (GcxM 
IgG F(ab')2; 10 ~g/ml, hatched bars), 3G8 (1/~g/ml) alone 
(solid bars), or 3G8 and crosslinking  (dotted bars). The in- 
cubation time  for mAbs and crosslinking  Abs was 3 rain 
each. Soluble  inositol  phosphates  were  assayed  as described 
in Materials and Methods. Values represent percent in- 
crease in IP3 production of nonstimulated  cells. Mean 
values of separate experiments are shown (n  = 3). SD 
never >10%. (B) Stimulation  of Fc~RIIIA  in transfected 
Jurkat cells results in activation of a tyrosine kinase. 
[32p]orthophosphate-labeled cells were either unstimu- 
lated (control), stimulated  with 3G8 (1.7 #g/ml), stimu- 
lated with 3G8 and crosslinked  with GccM IgG F(ab'): 
(3.2/~g/ml; 3G8+GcxM), stimulated  with OKT3 (1.2 
/~g/ml) and crosslinking  (OKT3+GcxM) at 37~  The 
incubation time for mAbs and crosslinking  Abs was 2.5 
rain each. Lysates  were  immunoprecipitated  with the an- 
tiphosphotyrosine  antibody  4G10 and protein  A sepharose 
CL4B, and subsequently  analyzed  by SDS-PAGE as de- 
scribed in Materials and Methods. Each lane represents 
"~5  x  106 cells. 
domains (2,  3),  resulting in the simultaneous crosslinking 
of multiple FcyRs. In addition, the mAbs themselves  can 
trigger Fc'yRs through their Fc portions, confounding in- 
terpretation of results.  These  obstacles  have made it very 
difficult to designate the role of one particular type of Fc'yR 
with a specific signal transduction event, and has resulted in 
conflicting results. This is particularly the case in neutrophils, 
where all three different types of Fc'yRs are expressed (2, 3), 
and where the spectrum of the proposed function in terms 
of signal transduction by FcyRIIIB is very broad. Some reports 
describe it as a completely nonfunctional  receptor that mediates 
only ligand binding without any further implication for cell 
activation  (31, 32).  Other  studies  have  concluded  that 
FcyglIIB is a receptor that is able to mediate signals only 
because of coexpression  of additional classes of FcyRs (33), 
and some reports describe it as a fully functional cell-surface 
receptor signalling independently (34). 
Several experimental approaches have attempted to dissect 
the contribution of the different Fc'yRs on neutrophils to 
the overall signal transduction responses.  F(ab)  and F(ab')2 
fragments have been used to target specific FcyRs and to pre- 
vent possible  receptor crosslinking due to Fc binding.  Al- 
though this approach seems to be suitable,  it requires  those 
fragments to be essentially free of remaining intact IgG, since 
contaminating amounts of as little as 1% are still able to ac- 
tivate cells by receptor crosslinking with other Fc3~Rs (35). 
The use of PI-PLC to deplete Fc3,RIIIB on neutrophils also 
fails since there is a remaining PI-PLC-resistant population 
of Fc'yRIIIB that still might interfere with other receptors 
by crosslinking (34). Experiments have also been done using 
neutrophils from patients with acquired paroxysmal nocturnal 
hemoglobinuria (PNH) which have a deficiency in the GPI 
membrane-attachment mechanism (7, 8). However, even those 
cells retain about  10%  of the normal level of cell  surface- 
expressed  FcyRIIIB, which  could contribute  to  FcyRII- 
Fc'yRIII crosslinking. Studies that have accounted for these 
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Figure 4.  (A) Induction  of 11:2 production. 
Nontransfected  Jurkat cells (open bars), Jurkat 
cells expressing  FcyRIIIA~+  y  (hatched ban), 
or Fc"/RIIIB  (solid bars) were stimulated  with 
the indicated  mAb in GotM  IgG-coated  micro- 
titer wells in the presence of PMA (10 ng/ml) 
for 24 h as described  in Materials  and Methods. 
II:2 secretion  was determined  by the ability  of 
culture supernatants  of stimulated  cells to sup- 
port the growth  of Ib2-dependent  CTLL  cells. 
Values represent  percent  increase  over  nonstimu- 
lated control cells, and are mean values from 
triplicate determinations  of one experiment  rep- 
resentative of two others. (B) Stimulation  of 
Fcq,  RIIIA induces expression of 11:2Rot in 
transfected  Jurkat cells. Flow  cytometry  of  cells 
stimulated  for 16 h with a control  mAb (32.2, 
dotted lines), OKT3 (dashed lines), or 3G8 (solid 
lines). Cells were incubated with biotin-con- 
jugated anti-11:2Rc~ mAb and labeled with 
fluorescein-coupled streptavidin. Stimulation 
was performed  using fixed crosslinking anti- 
bodies as described  in Materials and Methods. 
PMA was present at nonstimulatory  amounts 
of 10 ng/ml. 
difficulties have concluded that Fc3'RIIIB on neutrophils is 
unable to mediate ADCC, phagocytosis, [Ca2+]i or PIP2 hy- 
drolysis (31, 32,  36). 
To clarify the signal transduction potential of Fc3"RIII in 
a simplified background, we transfected the cDNA of these 
receptors into different cell lines. Expression of Fc3'RIIIB was 
independent of coexpression of FceR3', and the receptor mol- 
ecule was not found to be associated with any other cellular 
proteins approximating the in vivo situation for neutrophils. 
Our results strongly suggest that there is no evidence that 
Fc3'RIIIB is able  to elicit signal transduction after ligand 
binding and subsequent crosslinking. Transmembrane sig- 
nalling and stimulation of cell proliferation have been demon- 
strated for other GPI-linked proteins, most notably on T cells. 
Jurkat cells have been shown to be activated through trans- 
fected GPI-linked Thy-1 in the presence of TCR/CD3 (37). 
Under similar conditions, we are unable to elicit Fcq'RIIIB- 
dependent Jurkat cell activation. A recent report indicated 
that a number of different GPI-linked cell surface molecules 
are physically associated  with the tyrosine kinase lck (38). 
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Figure 5.  Cell  surface  expression  of 
Fc'yRIIIA in transfected P815 cells. 
Nontransfected  P815 cells (dotted line), 
P815 expressing  Fcq'RIIIAot+  "/(solid 
line), and P815 expressing  Fc3,RIIIA- 
et/3/(dashed line) were incubated  with 
3G8 followed  by labeling with fluo- 
rescein-conjugated GotM F(ab')2. 
Nonspecific staining  was assessed  by 
using an isotype-matched  negative 
control mAb 32.2, and was com- 
parable with the P815 control (data 
not shown). 
We have detected expression  of lck in our transfected Jurkat 
cells, and did not see any induction of tyrosine phosphoryla- 
tion after engagement of the GPI-linked Fc3,RIIIB. 
In contrast, signal transduction by the Fc3'RIIIA complex 
has been studied mostly in NK cells (31, 32), where it is the 
only one type of Fc3,R expressed (39). A number of cell acti- 
vation events have been reported to occur upon engagement 
of the Fc3'RIIIA complex, including proximal responses such 
as increases in [Ca2+]i, PIPz hydrolysis (31), as well as distal 
responses  such as  the transcriptional activation of specific 
cytokines like interferon-'), and TNF (32). It has been demon- 
strated that in NK cells, FcyRIIIAot is associated with either 
3'2, ~'~, or 3'~" (12, 13). This association is necessary to pre- 
vent the receptor complex from degradation during processing 
in the ER (16). Since both 3' and ~" share extensive sequence 
homology, and the ~" chain has been shown to elicit signalling 
through the TCR/CD3 (40), FcetLI3' is likely to be the poten- 
tial signal-transducing molecule of the FcqcRIIIA complex. 
A T cell line that has the signal transduction machinery used 
by ~" might therefore represent a useful model to investigate 
functional properties of 3' and its contributions to signal trans- 
duction through the Fc3'RIIIA complex. 
In  this  report  we  present  a  functional  model  for 
Fc3,RIIIAot+ 3' in the T cell line Jurkat, a system that allows 
investigation of both proximal and distal signal transduction 
responses. The transfected Fc3,RIIIA complex was functional, 
and the signals obtained were qualitatively and quantitatively 
similar to those obtained by activation through the TCR/CD3 
complex. This result further illustrates that TCR/CD3~" and 
FceRI3" share extensive sequence homology and have similar 
roles in receptor assembly, as well as in signal transduction. 
Several recent studies have demonstrated ~" chain cytoplasmic 
sequences to be necessary and sufficient to trigger T cell acti- 
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Figure 6.  (A) Calcium mobilization of Fc"/RIIIA in 
transfected P815 cells. Nontransfected P815, cells trans- 
fected with FcTRIIIA~+  3', or FcyRIIIA(~/-y) loaded 
with fura-2/AM were stimulated with anti-Fe-),RIII  mAb 
(3G8, 0.1/~g/ml), and subsequently  crosslinked  with Go~M 
F(ab')2 (10/~g/ml). Murine thrombin (0.1 U/ml) was 
used as a positive control. Cells were analyzed for changes 
in [Ca2+]i by fluorometry as described in Materials and 
Methods. Stimuli were added at times indicated (arrows). 
(B) Stimulation of PIP2 hydrolysis  in P815 cells expressing 
FcyRIIIA. Cells  loaded  with  myo-[3H]-inositol were 
stimulated for 3 min at 37~  with 3G8 (1/~g/ml). Soluble 
inositol phosphates were assayed as described in Materials 
and Methods.  Values represent  percent  increase in IP 
production of nonstimulated cells and are mean values  from 
triplicate determinations of one experiment representative 
of three others.  SD never >10%. 
vation when coupled to a heterologous extracellular domain. 
Thus, CD8/~,  CD4/~, and IL-2Roe/~" chimeras are able to 
trigger proximal and distal signals upon crosslinking (20, 41, 
44).  Further experiments will be required to determine the 
possible differences in cell activation by 3' as compared with ~'. 
By successfully expressing a functional Fcyg complex in 
a heterologous T cell system, we demonstrate the capability 
of this receptor to elicit signal transduction independent of 
NK cell-specific proteins. Stimulation of this receptor com- 
plex results in activation of both PIP2 hydrolysis and tyro- 
sine kinase activity. In addition, distal activation events such 
as the increase in IL-2Rc~ expression and production of IL-2 
confirm  the  physiologic  manner  of the  receptor-induced 
signals, Our findings, that the signals transduced by the cyto- 
plasmic deletion mutant FcyRIIIAc~ (A) + 3' are indistinguish- 
able from those generated by the wild-type Fc3'RIIIAc~+ y, 
suggest that the c~ cytoplasmic domain is not required for 
Fc3'RIIIA-mediated signalling.  In addition, the chimeric or~3" 
molecule demonstrates that  the 3'  subunit  couples ligand 
binding to intracellular signalling.  Since a number of different 
tyrosine kinases  such as fyn and lck have been found to be 
expressed in Jurkat cells (unpublished results), and can also 
be found to be activated by the CDS/~" (20), 3, may also pro- 
vide a direct link between Fc3'RIIIAot and these tyrosine 
kinases. 
Fc3,RIIIAe~+ 3' is expressed on the cell surface of NK cells, 
macrophages, and mast cells. We have extended our studies 
using the murine myeloid mastocytoma cell line P815. Our 
results demonstrate that Fc3'RIIIAo~+ 3' is functional in both 
lymphoid  and  myeloid  backgrounds.  We  have  recently 
identified an additional chain in the Fc3'RIIIAoe+ 3" complex 
in murine mast cells, the B chain of the FceRI complex (43). 
This finding suggested the possibility that B-like molecules 
may be responsible for signalling for FcyRIIIA receptors. 
However, coexpression of Fc3"RIIIAc~, B, 3" in CHO cells 
did not reconstitute receptor signalling. These data further 
indicate that the signal transducing capability of Fc3'RIIIA 
requires cell type-restricted molecules, in addition to c~, B, 
and 3'. 
Our studies to date have dissected several functional do- 
mains for the Fc3'RIIIA complex: (a) the extraceUular do- 
main  of Fc3"RIIIAot  subunit  provides  ligand  recognition 
(9-11);  (b) the transmembrane domain of this subunit deter- 
mines the half-life of the subunit in the ER and mediates 
3' chain assembly; (c) the transmembrane domain of the 3' 
subunit prevents ER degradation of the c~ subunit (16); and 
(d) the cytoplasmic domain of 3' initiates intracellular sig- 
nalling events. The mechanism by which the 3" cytoplasmic 
domain initiates these events upon receptor crosslinking is 
now open for dissection. 
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